Cargando…

Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis

BACKGROUND: Gouty arthritis (GA) is a chronic disease caused by monosodium urate crystal deposition. Repeated attacks of arthritis may lead to the deposition of urate to form gout stone, resulting in joint deformity and joint damage. Although GA is not fatal, it causes low work productivity and low...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Meng-jun, Yao, Cheng-jiao, Liu, Li-ming, Ren, Li-jun, Li, Yong-li, Xie, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837833/
https://www.ncbi.nlm.nih.gov/pubmed/33545937
http://dx.doi.org/10.1097/MD.0000000000023699
_version_ 1783643033729761280
author Pu, Meng-jun
Yao, Cheng-jiao
Liu, Li-ming
Ren, Li-jun
Li, Yong-li
Xie, Yan
author_facet Pu, Meng-jun
Yao, Cheng-jiao
Liu, Li-ming
Ren, Li-jun
Li, Yong-li
Xie, Yan
author_sort Pu, Meng-jun
collection PubMed
description BACKGROUND: Gouty arthritis (GA) is a chronic disease caused by monosodium urate crystal deposition. Repeated attacks of arthritis may lead to the deposition of urate to form gout stone, resulting in joint deformity and joint damage. Although GA is not fatal, it causes low work productivity and low quality of life. Western drug, such as febuxostat, colchicine, allopurinol, often cannot get satisfying curative effect, and may even lead to serious side effects, such as exfoliative dermatitis or uremia. However, the therapeutic effect of Traditional Chinese medicine is very satisfactory. The treatment effect of simiao powder, a Chinese patent medicine, combined with acupuncture was widely used on treatment of GA. Although it has been widely used in clinical practice, its relative effectiveness and safety have not been confirmed. Therefore, this study will use meta-analysis to verify the efficacy and safety of simiao powder combined with acupuncture in the treatment of GA. METHODS: All randomized controlled trial of simiao powder combined with acupuncture for the treatment of RA from their inception 29 October, 2020 will be searched form the China National Knowledge Infrastructure, Wanfang Database, Chinese Science and Technology Periodical Database, Chinese Biomedical Literature Database, Pubmed, Embase, Web of Science, and the Cochrane library. Two authors will independently select studies, extract data based on pre-designed inclusion and exclusion criteria. Methodological quality assessment and risk of bias will be assessed using Cochrane bias risk tool. All data analysis will be conducted using Revman5.3, WinBUGS 1.4.3, and Stata14.2 software. RESULTS: We will compare the different outcome indicators of various studies to provide a synthesis of the efficacy and safety of Simiao powder combined with acupuncture for GA patients. The main outcome measures included efficacy, remission rate (no drug symptoms), recurrence rate, clinical absolute score and relative score. Secondary outcome measures included related adverse reactions and uric acid concentration. CONCLUSION: The findings of the study will provide helpful evidence for the efficacy and safety of simiao powder combined with acupuncture in the treatment of GA. REGISTRATION NUMBER: This study protocol have been funded through a protocol registry. The registry number is INPLASY2020110028
format Online
Article
Text
id pubmed-7837833
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78378332021-01-27 Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis Pu, Meng-jun Yao, Cheng-jiao Liu, Li-ming Ren, Li-jun Li, Yong-li Xie, Yan Medicine (Baltimore) 6900 BACKGROUND: Gouty arthritis (GA) is a chronic disease caused by monosodium urate crystal deposition. Repeated attacks of arthritis may lead to the deposition of urate to form gout stone, resulting in joint deformity and joint damage. Although GA is not fatal, it causes low work productivity and low quality of life. Western drug, such as febuxostat, colchicine, allopurinol, often cannot get satisfying curative effect, and may even lead to serious side effects, such as exfoliative dermatitis or uremia. However, the therapeutic effect of Traditional Chinese medicine is very satisfactory. The treatment effect of simiao powder, a Chinese patent medicine, combined with acupuncture was widely used on treatment of GA. Although it has been widely used in clinical practice, its relative effectiveness and safety have not been confirmed. Therefore, this study will use meta-analysis to verify the efficacy and safety of simiao powder combined with acupuncture in the treatment of GA. METHODS: All randomized controlled trial of simiao powder combined with acupuncture for the treatment of RA from their inception 29 October, 2020 will be searched form the China National Knowledge Infrastructure, Wanfang Database, Chinese Science and Technology Periodical Database, Chinese Biomedical Literature Database, Pubmed, Embase, Web of Science, and the Cochrane library. Two authors will independently select studies, extract data based on pre-designed inclusion and exclusion criteria. Methodological quality assessment and risk of bias will be assessed using Cochrane bias risk tool. All data analysis will be conducted using Revman5.3, WinBUGS 1.4.3, and Stata14.2 software. RESULTS: We will compare the different outcome indicators of various studies to provide a synthesis of the efficacy and safety of Simiao powder combined with acupuncture for GA patients. The main outcome measures included efficacy, remission rate (no drug symptoms), recurrence rate, clinical absolute score and relative score. Secondary outcome measures included related adverse reactions and uric acid concentration. CONCLUSION: The findings of the study will provide helpful evidence for the efficacy and safety of simiao powder combined with acupuncture in the treatment of GA. REGISTRATION NUMBER: This study protocol have been funded through a protocol registry. The registry number is INPLASY2020110028 Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837833/ /pubmed/33545937 http://dx.doi.org/10.1097/MD.0000000000023699 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6900
Pu, Meng-jun
Yao, Cheng-jiao
Liu, Li-ming
Ren, Li-jun
Li, Yong-li
Xie, Yan
Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title_full Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title_fullStr Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title_full_unstemmed Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title_short Traditional Chinese medicine for gouty arthritis: A protocol for meta-analysis
title_sort traditional chinese medicine for gouty arthritis: a protocol for meta-analysis
topic 6900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837833/
https://www.ncbi.nlm.nih.gov/pubmed/33545937
http://dx.doi.org/10.1097/MD.0000000000023699
work_keys_str_mv AT pumengjun traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis
AT yaochengjiao traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis
AT liuliming traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis
AT renlijun traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis
AT liyongli traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis
AT xieyan traditionalchinesemedicineforgoutyarthritisaprotocolformetaanalysis